Sterling Silver Golf Ball & Tee Cufflinks - On Sale

Dream of improving your slice while wearing these original cufflinks at work, and maybe you’ll actually get better. The Sterling Silver Golf Ball & Tee Cufflinks are the perfect accessory for the golf lover to accessorize his or her wardrobe. The sterling silver 3/8” golf ball is a perfect replica, while on the opposite end a ¾” tee is featured. You get to choose which side you will wear on the exterior, so you are really getting two types of cufflinks for the price of one. There’s no doubt that golf lovers will adore these Sterling Silver Golf Ball & Tee Cufflinks.

NEW YORK (Reuters) - A subtle peace has emerged in Wall Street’s long-running broker recruiting wars, Morgan Stanley Chief Executive Officer James Gorman said on Wednesday. Firms like Morgan Stanley have realized they no longer need to depend on poaching employees from rivals to boost revenue, he said, and are focused instead on earning more from a stable roster of existing brokers. “The amount of recruiting they’re doing from each other is very small, and it’s small for good reason though,” Gorman said on a conference call with analysts to discuss second-quarter results. “We don’t need to recruit a lot of people. We’re growing organically.”.

For most of their history, full-service wealth management firms have offered recruiting bonuses to lure away competitors’ best brokers, and by extension, their clients, The number of those firms has dwindled as the industry consolidated, while small independent advisory offices have proliferated, Brokerages have pulled back on costly recruiting over the past year and are instead giving brokers incentives to bring on new clients and squeeze more assets from existing ones, The number of firms recruiting from each other has shrunk from 10 to roughly four over the past 25 years, Gorman said, referring to Morgan Stanley, Bank of America’s sterling silver golf ball & tee cufflinks Merrill Lynch Wealth Management, Wells Fargo Advisors and UBS Group AG’s U.S, wealth management division..

Gorman’s comments come less than a year after Morgan Stanley and UBS left a pact with Merrill, Wells Fargo and others agreeing to terms for broker departures, a step that led to a massive reduction in lawsuits firms filed after brokers decamped for rivals. “We’re, honestly, (experiencing) very little attrition, and as a result, we are doing very little recruiting,” Gorman said. “We like growing in-house and we’re doing that successfully, and clearly, it’s an economically .. better proposition.”.

Morgan Stanley reported 15,632 brokers as of June 30, flat from the previous quarter and down about 1 percent from the prior year, Bank of America’s Merrill Lynch Wealth Management reported earlier this week that its headcount of 14,820 was sterling silver golf ball & tee cufflinks essentially flat - down by 9 net brokers from last quarter and up by 9 over last year, Wells Fargo, which reported last week, said the 14,226 advisers in its retail brokerage declined by 1 percent from the prior quarter and by 2 percent over last year, UBS Group AG reports earnings on July 27..

ZURICH (Reuters) - Novartis (NOVN.S) may ratchet up its 2018 sales outlook, its finance chief said on Wednesday, despite halting planned U.S. drug price hikes amid pressure on the industry from President Donald Trump’s administration over the high cost of medicines. Shares in the Swiss drugmaker, whose decision to freeze prices this year in the world’s largest drug market was mirrored by Pfizer (PFE.N), closed 2.5 percent higher in Zurich after the firm beat forecasts with second-quarter results.

Second-quarter core operating profit rose 7 percent to $3.54 sterling silver golf ball & tee cufflinks billion, it said, better than the average forecast of $3.46 billion in a Reuters poll, Sales climbed 5 percent to $13.16 billion, topping the $12.92 billion forecast, Full-year 2018 sales are seen rising at low-to-mid single digit percentage rates, with operating profit rising in the mid-to-upper single digit percentages, But Chief Financial Officer Harry Kirsch told analysts on a conference call he expected “continued good momentum” for products including psoriasis-and-arthritis drug Cosentyx and heart-failure medicine Entresto, That increased the likelihood that Novartis would upgrade its sales targets for 2018, he said..

“You may see us raise (the guidance) in quarter three,” Kirsch said. “It’s a bit too early now, but I’m quite confident we will be at the upper end of the guidance on sales.”. This would come without price hikes as Novartis keeps the lid on medicine costs under pressure from U.S. lawmakers and Trump. A call from the president prompted Pfizer CEO Ian Read this month to reverse course on price hikes his company had enacted on July 1. Novartis said it made its own decision in June to forego what had been planned hikes, adding that a range of factors were considered.

Novartis Chief Executive Narasimhan told Reuters that, unlike Pfizer’s Read, he did not have a direct talk with Trump on drug prices but he said his company has been speaking to the federal Department of Health and Human Services about the U.S, administration’s “blueprint” to trim costs, “We don’t plan to take any further price increases in the United States for 2018,” the Novartis CEO said, “Right now, in a very dynamic environment in the United States ., we sterling silver golf ball & tee cufflinks view it as the prudent course.”..

Recent Posts